Skip to main content
Log in

Herpud1 deficiency alleviates homocysteine-induced aortic valve calcification

  • RESEARCH
  • Published:
Cell Biology and Toxicology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the role and therapeutic value of homocysteine (hcy)-inducible endoplasmic reticulum stress (ERS) protein with ubiquitin like domain 1 (Herpud1) in hcy-induced calcific aortic valve disease (CAVD).

Background

The morbidity and mortality rates of calcific aortic valve disease (CAVD) remain high while treatment options are limited.

Methods

In vivo, we use the low-density lipoprotein receptor (LDLR) and Herpud1 double knockout (LDLR−/−/Herpud1−/−) mice and used high methionine diet (HMD) to assess of aortic valve calcification lesions, ERS activation, autophagy, and osteogenic differentiation of aortic valve interstitial cells (AVICs). In vitro, the role of Herpud1 in the Hcy-related osteogenic differentiation of AVICs was investigated by manipulating of Herpud1 expression.

Results

Herpud1 was highly expressed in calcified human and mouse aortic valves as well as primary aortic valve interstitial cells (AVICs). Hcy increased Herpud1 expression through the ERS pathway and promoted CAVD progression. Herpud1 deficiency inhibited hcy-induced CAVD in vitro and in vivo. Herpud1 silencing activated cell autophagy, which subsequently inhibited hcy-induced osteogenic differentiation of AVICs. ERS inhibitor 4-phenyl butyric acid (4-PBA) significantly attenuated aortic valve calcification in HMD-fed low-density lipoprotein receptor−/− (LDLR−/−) mice by suppressing ERS and subsequent Herpud1 biosynthesis.

Conclusions

These findings identify a previously unknown mechanism of Herpud1 upregulation in Hcy-related CAVD, suggesting that Herpud1 silencing or inhibition is a viable therapeutic strategy for arresting CAVD progression.

Highlights

• Herpud1 is upregulated in the leaflets of Hcy-treated mice and patients with CAVD.

• In mice, global knockout of Herpud1 alleviates aortic valve calcification and Herpud1 silencing activates cell autophagy, inhibiting osteogenic differentiation of AVICs induced by Hcy.

• 4-PBA suppressed Herpud1 expression to alleviate AVIC calcification in Hcy treated AVICs and to mitigate aortic valve calcification in mice.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Data availability

All data will be shared upon reasonable request to the corresponding authors.

Abbreviations

Hcy:

Homocysteine

ERS:

Endoplasmic reticulum stress

Herpud1:

Hcy-inducible endoplasmic reticulum protein with ubiquitin like domain 1

CAVD:

Calcific aortic valve disease

AVICs:

Aortic valve interstitial cells

4-PBA:

4-Phenyl butyric acid

ND:

Normal chow diet

HMD:

High methionine diet

LDLR−/−:

Low-density lipoprotein receptor−/−

LDLR−/−/Herpud1−/− :

Low-density lipoprotein receptor (LDLR) and Herpud1 double knockout

UPR:

Unfolded protein response

ERAD:

ER-associated protein degradation

ND:

Normal chow diet

3-MA:

3-Methyladenine

ALP:

Alkaline phosphatase

Col1:

Collagen1

OPN:

Osteopontin

OC:

Osteocalcin

FDA:

Food and Drug Administration

β-GP:

β-Glycerophosphate

HASMCs:

Human aortic smooth muscle cells

CAVM:

Congenital aortic valve malformation

AVC:

Aortic valve calcification

OV:

Overexpression

LDL:

Low-density lipoprotein

TC:

Total cholesterol

TG:

Triglyceride

AVA:

Aortic valve area

BMI:

Body mass index

HDL:

High-density lipoprotein cholesterol

LVEF:

Left ventricular ejection fraction

LVIDd:

Left ventricular internal diameter during diastole

LVIDs:

Left ventricular internal diameter during systole

FS:

Functional shortening

MTPG:

Mean transvalvular pressure gradient

References

Download references

Acknowledgements

The authors thank Hangyuan Guo and Hui Lin for the support and guidance of this experiment, and Yue Shan, Zhuonan Wu, and others assisted in this experiment.

Funding

This work was supported by Natural Science Foundation of Zhejiang Province, China (No. LGF21H020001), Natural Science Foundation of China (No. 82200390), Zhejiang Province Medical and Health Science and Technology Program (No. 2022RC079), and Shaoxing Science and Technology Plan Project, China (No. 2020A13015 and No. 2020A13018).

Author information

Authors and Affiliations

Authors

Contributions

Wenqing Xie and Yue Shan completed most of the experiments and thesis writing. Zhuonan Wu, Nan Liu, Jinjin Yang, Hanlin Zhang, Shiming Sun, Jufang Chi, and Weizhong Feng participated in the analysis of experimental data. Hui Lin and Hangyuan Guo designed the experimental idea.

Corresponding authors

Correspondence to Hui Lin or Hangyuan Guo.

Ethics declarations

Ethical approval and consent to participate

All patients provided informed consent, and the study protocol was approved by the ethics committee of Shaoxing People’s Hospital (2020-56). The animal procedures were performed according to the Guide for the Care and Use of Laboratory Animals from the National Institutes of Health and approved by the Animal Care and Use Committee of Shaoxing People’s Hospital.

Conflicts of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 3727 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xie, W., Shan, Y., Wu, Z. et al. Herpud1 deficiency alleviates homocysteine-induced aortic valve calcification. Cell Biol Toxicol 39, 2665–2684 (2023). https://doi.org/10.1007/s10565-023-09794-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10565-023-09794-w

Keywords

Navigation